Evidence map›Paper›PMID 27864644›Full record

ReviewPflugers Archiv : European journal of physiology2017

Targeting and alteration of tight junctions by bacteria and their virulence factors such as Clostridium perfringens enterotoxin.

Miriam Eichner, Jonas Protze, Anna Piontek, Gerd Krause, Jörg Piontek

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pflugers Archiv : European journal of physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Computational and structural biotechnology journal · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Loss of Gut Barrier Integrity In Lupus.Frontiers in immunology · 2022
    Review
  17. Article
  18. Article
  19. Protective Effects ofInternational journal of molecular sciences · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Miriam EichnerInstitute of Clinical Physiology, Charité-Universitätsmedizin Berlin, 12203, Berlin, Germany.
Jonas ProtzeLeibniz-Institut für Molekulare Pharmakologie (FMP), 13125, Berlin, Germany.
Anna PiontekLeibniz-Institut für Molekulare Pharmakologie (FMP), 13125, Berlin, Germany.
Gerd KrauseLeibniz-Institut für Molekulare Pharmakologie (FMP), 13125, Berlin, Germany.
Jörg PiontekInstitute of Clinical Physiology, Charité-Universitätsmedizin Berlin, 12203, Berlin, Germany. joerg.piontek@charite.de.
Leibniz-Forschungsinstitut für Molekulare Pharmakologie · DECharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The integrity of tight junctions, which regulate paracellular permeability, is challenged by many bacterial pathogens. This is caused by inflammatory responses triggered by pathogens and direct interaction of bacteria or their toxins with host epithelial cells. In some cases, tight junction proteins represent receptors for cell surface proteins or toxins of the pathogen, such as Clostridium perfringens enterotoxin (CPE). CPE causes diarrhea and cramps-the symptoms of a common foodborne illness, caused by C. perfringens type A. It uses a subgroup of the claudin family of tight junction proteins as receptors and forms pores in the membrane of intestinal epithelial cells. Ca

Indexed as

AnimalsClostridium perfringensEnterotoxinsHumansTight Junction ProteinsTight JunctionsVirulence Factorsenterotoxin, ClostridiumEnterotoxinsTight Junction ProteinsVirulence FactorsBacterial receptorsClaudin targetingClostridium perfringens enterotoxinIntestinal barrierPore-forming toxin

Identifiers

PMID27864644
OpenAlexW2549336227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.